Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Siga Technologies Total Assets 2010-2025 | SIGA

Siga Technologies total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Siga Technologies Annual Total Assets
(Millions of US $)
2024 $244
2023 $254
2022 $195
2021 $215
2020 $150
2019 $199
2018 $203
2017 $145
2016 $161
2015 $186
2014 $161
2013 $194
2012 $106
2011 $90
2010 $27
2009 $26
Siga Technologies Quarterly Total Assets
(Millions of US $)
2025-06-30 $235
2025-03-31 $247
2024-12-31 $244
2024-09-30 $195
2024-06-30 $193
2024-03-31 $243
2023-12-31 $254
2023-09-30 $158
2023-06-30 $147
2023-03-31 $184
2022-12-31 $195
2022-09-30 $204
2022-06-30 $160
2022-03-31 $185
2021-12-31 $215
2021-09-30 $136
2021-06-30 $134
2021-03-31 $139
2020-12-31 $150
2020-09-30 $141
2020-06-30 $120
2020-03-31 $119
2019-12-31 $199
2019-09-30 $203
2019-06-30 $203
2019-03-31 $206
2018-12-31 $203
2018-09-30 $144
2018-06-30 $128
2018-03-31 $133
2017-12-31 $145
2017-09-30 $149
2017-06-30 $156
2017-03-31 $161
2016-12-31 $161
2016-09-30 $163
2016-06-30 $202
2016-03-31 $185
2015-12-31 $186
2015-09-30 $197
2015-06-30 $182
2015-03-31 $173
2014-12-31 $161
2014-09-30 $165
2014-06-30 $209
2014-03-31 $215
2013-12-31 $194
2013-09-30 $202
2013-06-30 $177
2013-03-31 $129
2012-12-31 $106
2012-09-30 $92
2012-06-30 $93
2012-03-31 $89
2011-12-31 $90
2011-09-30 $51
2011-06-30 $52
2011-03-31 $23
2010-12-31 $27
2010-09-30 $24
2010-06-30 $22
2010-03-31 $24
2009-12-31 $26
2009-09-30 $8
2009-06-30 $8
2009-03-31 $7
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.627B $0.139B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $69.638B 26.78
Zoetis (ZTS) United States $68.964B 25.02
Takeda Pharmaceutical (TAK) Japan $48.715B 9.94
Daiichi Sankyo, - (DSNKY) Japan $47.927B 24.56
BeOne Medicines - (ONC) Switzerland $34.411B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.721B 0.00
Summit Therapeutics (SMMT) United States $19.321B 0.00
Merck (MKKGY) Germany $16.724B 10.87
Shionogi (SGIOY) Japan $14.853B 14.88
United Therapeutics (UTHR) United States $14.013B 12.13
Neurocrine Biosciences (NBIX) United States $13.417B 40.02
IPSEN (IPSEY) France $11.320B 0.00
Orion OYJ (ORINY) Finland $11.248B 27.11
Eisai (ESAIY) $9.064B 10.22
Madrigal Pharmaceuticals (MDGL) United States $9.039B 0.00
Corcept Therapeutics (CORT) United States $7.479B 62.81
Grifols, S.A (GRFS) Spain $6.931B 0.00
Stevanato Group S.p.A (STVN) Italy $6.920B 40.80
Ionis Pharmaceuticals (IONS) United States $6.891B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Soleno Therapeutics (SLNO) United States $3.710B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.225B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.993B 14.22
Crinetics Pharmaceuticals (CRNX) United States $2.769B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.753B 0.00
Hypermarcas (HYPMY) Brazil $2.692B 20.24
Catalyst Pharmaceuticals (CPRX) United States $2.516B 8.43
Centessa Pharmaceuticals (CNTA) United Kingdom $2.348B 0.00
Ocular Therapeutix (OCUL) United States $2.111B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.759B 0.00
Dyne Therapeutics (DYN) United States $1.738B 0.00
Guardian Pharmacy Services (GRDN) United States $1.665B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.590B 23.69
Ardelyx (ARDX) United States $1.472B 0.00
ARS Pharmaceuticals (SPRY) United States $1.470B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.439B 0.00
Harrow (HROW) United States $1.412B 0.00
Evotec AG (EVO) Germany $1.257B 0.00
Collegium Pharmaceutical (COLL) United States $1.245B 6.80
Xeris Biopharma Holdings (XERS) United States $1.226B 0.00
Enliven Therapeutics (ELVN) United States $1.175B 0.00
Cronos Group (CRON) Canada $0.981B 0.00
Akebia Therapeutics (AKBA) United States $0.846B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.753B 7.76
Amylyx Pharmaceuticals (AMLX) United States $0.752B 0.00
Theravance Biopharma (TBPH) United States $0.688B 56.92
ProKidney (PROK) United States $0.679B 0.00
KalVista Pharmaceuticals (KALV) United States $0.647B 0.00
Elite Pharmaceuticals (ELTP) United States $0.594B 0.00
Tourmaline Bio (TRML) United States $0.592B 0.00
Relay Therapeutics (RLAY) United States $0.588B 0.00
Bioventus (BVS) United States $0.585B 14.16
Organogenesis (ORGO) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.560B 11.47
Oruka Therapeutics (ORKA) United States $0.554B 0.00
Zevra Therapeutics (ZVRA) United States $0.534B 0.00
Nektar Therapeutics (NKTR) United States $0.533B 0.00
Xencor (XNCR) United States $0.531B 0.00
Savara (SVRA) United States $0.527B 0.00
Nanobiotix S.A (NBTX) France $0.467B 0.00
Esperion Therapeutics (ESPR) United States $0.429B 0.00
Aquestive Therapeutics (AQST) United States $0.390B 0.00
Aldeyra Therapeutics (ALDX) United States $0.352B 0.00
4D Molecular Therapeutics (FDMT) United States $0.320B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.314B 0.00
Altimmune (ALT) United States $0.312B 0.00
Larimar Therapeutics (LRMR) United States $0.305B 0.00
Nature's Sunshine Products (NATR) United States $0.293B 19.13
AleAnna (ANNA) United States $0.281B 0.00
Lexeo Therapeutics (LXEO) United States $0.258B 0.00
Galectin Therapeutics (GALT) United States $0.249B 0.00
OmniAb (OABI) United States $0.221B 0.00
Lyell Immunopharma (LYEL) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
Korro Bio (KRRO) United States $0.193B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.191B 29.50
Aclaris Therapeutics (ACRS) United States $0.190B 0.00
MediWound (MDWD) Israel $0.188B 0.00
China SXT Pharmaceuticals (SXTC) China $0.182B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.165B 0.00
MEI Pharma (MEIP) United States $0.150B 0.00
Achieve Life Sciences (ACHV) Canada $0.148B 0.00
Profound Medical (PROF) Canada $0.138B 0.00
Avita Medical (RCEL) United States $0.126B 0.00
Inhibikase Therapeutics (IKT) United States $0.125B 0.00
Avalo Therapeutics (AVTX) United States $0.123B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.119B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Champions Oncology (CSBR) United States $0.102B 23.16
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
Surrozen (SRZN) United States $0.097B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
Pyxis Oncology (PYXS) United States $0.082B 0.00
VAXART, INC (VXRT) United States $0.082B 0.00
Context Therapeutics (CNTX) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
Liminatus Pharma (LIMN) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Metagenomi (MGX) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.065B 0.00
Wellgistics Health (WGRX) United States $0.064B 0.00
Prelude Therapeutics (PRLD) United States $0.062B 0.00
Inotiv (NOTV) United States $0.060B 0.00
DURECT (DRRX) United States $0.059B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Karyopharm Therapeutics (KPTI) United States $0.052B 0.00
Jupiter Neurosciences (JUNS) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Fractyl Health (GUTS) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 29.45
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Plus Therapeutics (PSTV) United States $0.048B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Klotho Neurosciences (KLTO) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
Aptorum Group (APM) United Kingdom $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Mangoceuticals (MGRX) United States $0.017B 0.00
Scienture Holdings (SCNX) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Incannex Healthcare (IXHL) Australia $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Carisma Therapeutics (CARM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
CDT Equity (CDT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.51
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.63
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00